CV Sciences (OTCMKTS: CVSI) a Las Vegas, Nevada-based manufacturer and supplier of hemp CBD products recently announced its plans to expand its dominant PlusCBD Oil Brand. The expansion will see distribution of the topical PlusCBD Oil Extra Strength Balm, into the Food, Drug and Mass (FDM) channel. CV Sciences was also proud to make public the 48% growth in the number of retail store selling its PlusCBD Oil branded products from 2,238 as of 31st December 2018 to 3,308 as of 31st March 2019.
CV Sciences’ Chief Executive Officer, Joseph Dowling said, “The passage of the 2018 Farm Bill has accelerated our business development activities and expanded our distribution to new food, drug, mass merchandise retailers. We are at an important stage in the development of the hemp-based CBD market, and the company is well-positioned to capitalize on both growing consumer demand and the benefit of enhanced regulation that supports and ensures the safest and highest hemp-based CBD products for consumers.”
The Financial Result for First Quarter 2019
The company has announced that it will make known its financial report for the first quarter of 2019 after the close of trading on Wednesday 8th May 2019. Consequently, the company will be having a conference call with the investment community on that day at 1:30 p.m. Pacific Time (4:30p.m. Eastern Time). Investors in the United States who want to be a part of the live call can dial (877) 407-0784 while international participants can dial (201) 689-8560.
The conference call webcast will be available for all on the CV Sciences website’s Investor Relations section. The webcast will be archived for about 30 days. Also, about two hours after the end of the conference call, a telephone replay will be made available until 15th May 2019. You can have access to the telephone replay by dialing the number (844) 512-2921 from the United States or (412) 317-6671 from international locations and keying in the confirmation code 13690537.
Curious about how you can make money investing in cannabis? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.